Logo
Menu
  • Solutions
  • Technology
  • Company
  • Research
  • Blog
Download the app

Research

  • Medisafe delivers high rates of adherence now and beyond the first fill - no matter how complex the dosing. We can prove it.

  • Adherence

    Medisafe Improves Adherence and Lowers Costs For Chronic Disease Patients

    Medisafe collaborated with IMS Health to conduct a study evaluating med adherence among Medisafe users with hypertension, hyperlipidemia and diabetes against a control group.Read more.

    Social Support

    The Impact of Medisafe’s ‘Medfriend’ caregiver feature on Adherence

    Medisafe analyzed 1,617 non-adherent active users two weeks before and two weeks after they added a Medfriend. 71% of users improved medication adherence after adding a Medfriend.Read more.

    Adherence

    Medisafe Significantly Lowers Users’ Blood Pressure

    Medisafe app users experienced significant improvements in their blood pressure levels over a 30-day period, with stage 2 hypertensives decreasing their systolic blood pressure by 25.3 mmHg.Read more.

  • Research Highlights

    • -25.3%

      Systolic blood pressure reduction for Stage 2 hypertensive users
    • -17.7mm
      Hg

      Systolic blood pressure reduction for Stage 1 hypertensive users
    • 86%

      of Stage 2 hypertensive Medisafe users reduced their risk category to Stage 1 or below
  • Do you need rapid understanding of patient behavioral trends so you can make informed, agile, and data-driven decisions? Impact your bottom line – contact us today.

    Let's work together

    • Our Research Partners


    © Medisafe 2017

    Highlights

    • Our research
    • Testimonials
    • Mission
    • Careers
    • Press

    Support

    • Help center
    • Contact us

    Social

    • Facebook
    • Twitter
    • LinkedIn
    • Instagram
    • Google+

    Legal

    • Terms & conditions
    • Privacy policy